There is not a single statistically rigorous human trial demonstrating successful transdermal absorption of a GLP-1 drug
Endurance work feels smoother
Vancampfort D, Mugisha J, Hallgren M, De Hert M, Probst M, Monsieur D, et al
The timing of medication resumption after colonoscopy should also be discussed, typically allowing restart once normal oral intake is tolerated
Currently, tirzepatide is the most promising listed incretin analogue
Medicaid coverage All state Medicaid programs cover GLP-1s for type 2 diabetes, but weight loss coverage is optional and left to each state